KENKO TECHNOLOGY

Scientific Team

Inspired by Academia

Scientific and Medical Advisors

To build a versatile machine learning algorithm, one needs to gather a large amount of data. The data has to describe as accurately as possible the wide spectrum of emotional responses to a stimulus. For this task we planned two different experiments, one focuses on stress specifically and the other focuses on affective responses.

Graduated from University of Tokyo, Faculty of Medicine in 1986 and started training in clinical psychiatry at Teikyo University School of Medicine, Tokyo. In 1991, he obtained qualification as a psychiatrist from the Ministry of Health and Welfare, Japan, and started to work as a research associate in the Department of Psychiatry at Teikyo University School of Medicine.  

He obtained Ph.D. from University of Tokyo in 1994 and then started molecular genetics study at the Department of Psychological Medicine at the Institute of Psychiatry, London, until 1995.  In 1998 he was promoted to assistant Professor at the Department of Psychiatry, Teikyo University School of Medicine.  

In 2002, he was appointed Director at the Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan (present position).  He has been visiting Professor of Bioscience at Waseda University Faculty of Science and Engineering since 2004 and Yamanshi University Faculty of Medicine as of 2011.

Prof. Hiroshi Kunugi (MD)

Prof. Yonatan Halevy (MD)

Prof. Halevy is a medical specialist in internal medicine, digestive tract diseases and healthcare administration. He is also a Clinical Professor of Medicine at the Hebrew University Medical School.

Prof. Halevy is a Director at Van Leer Ventures Jerusalem, as well as the Chairman at Shaare Zedek Medical Center. Prof. Halevy plays a key role in quality improvement programs and medical risk management in Israeli healthcare institutions, serving as the Chairman of the Medical Risk Management Forum in the Medical Risk Management.

Dr. Ofer Sharon (MD)

Dr. Ofer Sharon is a physician (internist) and entrepreneur with extensive experience in both clinical and commercial product development for startups in health tech, biotech, and medical devices. Ofer’s previous companies developed products that utilized change detection algorithms to identify clinical deterioration and intervene early to improve clinical outcomes. In the years 2011-2016 Ofer served as the Chief Medical Officer for Merck Israel, in this capacity Ofer founded a big data research collaborations.

Ofer’s main fields of interest include development and implementation of change detection algorithms for medical use and the development of patient engagement strategies with focus on complex medical situations and chronic diseases. Ofer is a Major (res.) in the IDF and a medical company commander with specific expertise on disaster areas and hazardous materials. Dr. Sharon serves on the boards of several companies and mentors several healthcare startups in Israel.

Dr. Hiroyuki Suzuki

Dr. Hiroyuki Suzuki holds a B.S., M.S., and Ph.D. degrees in Science from the University of Tokyo, Japan. In 2007, Dr. Suzuki moved to Advanced Telecommunications Research Institute International (ATR), Kyoto, as a Vice President, Director, and in 2010 he became the Senior Vice President, Director. He is now the Executive Vice President, Representative Director, Head of Strategic Management Unit and Business Development Office, of ATR, and is in charge of corporate management and planning, and business developments, of ATR and ATR Group.

Dr. Suzuki is also a strategic director and the leader of Innovation Hub Activity of Keihanna Research Complex Project of Japan Science and Technology Agency (JST), in which he is creating a global innovation ecosystem together with local governments, big companies, SMEs, startups, universities, research institutes, and local residents.

Dr. Suzuki has published more than 300 scientific papers in international scientific journals and books, and holds more than 60 patents.

In his research, Prof. Chen focuses on the biological processes by which stress and anxiety develop in our bodies, as well as the mechanisms in the brain that are activated by these mental states and which are meant to regulate them. He is the head of the Neurobiology Department at the Weizmann Institute of Science, as well as a director at the Max Planck Institute of Psychiatry in Munich, Germany. Additionally, on December 1st, 2019, Prof. Chen will take office as the next president of the Weizmann Institute of Science.

Our experiments were inspired by the work of Prof. Chen. From the first moment of designing an experiment to the last stage of analyzing the results, Prof. Chen's work served as an amazing reference and a golden standard. Thanks to these experiments we gathered high-quality data for building our Emotion AI.